Safecode Drug (SAFC) 0.0028 $SAFC Kentico Partners with

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Safecode Drug (SAFC) 0.0028 $SAFC

Kentico Partners with Scrum Alliance and Powers New Website
PR Newswire - Tue Jan 28, 8:00AM CST
Kentico Software, the web content and Customer Experience Management provider, announced today it was used by digital agency Burns Marketing to power the new Scrum Alliance website and has partnered with the organization to help promote the benefits of its Agile framework, Scrum, to the Kentico customer community.

Broward Public Library Foundation's Annual LitLUNCH! Features Prolific and Entertaining Author Jen Lancaster
PR Newswire - Fri Jan 17, 12:40PM CST
As a kick-off to Literary Feast 2014, the Broward Public Library Foundation will hold its annual LitLUNCH! event on Friday, February 21, 2014 beginning at 11:30 a.m. at the Pier Top Lounge at the Hyatt Regency Pier Sixty-Six (2301 S.E. 17th Street, Fort Lauderdale). This year, LitLUNCH! features Jen Lancaster, the hilariously funny author of nine bestsellers, the latest of which is The Tao of Martha: My Year of LIVING, or Why I'll Never Be Able to Get All That Glitter Off the Dog.

The Zacks Analyst Blog Highlights:Unisys, Broadcom, Marvell Technology Group, Infosys and Big 5 Sporting Goods
PR Newswire - Wed Jan 15, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Unisys Corporation (NYSE:UIS-Free Report), Broadcom Corp (Nasdaq:BRCM-Free Report), Marvell Technology Group Ltd (Nasdaq:MRVL-Free Report),Infosys Ltd (NYSE:INFY-Free Report) and Big 5 Sporting Goods Corp. (Nasdaq:BGFV-Free Report).

36.5 Million Americans Would Be Unable to Wake Up on Time Without Smartphone Apps
Marketwire - Thu Dec 19, 8:01AM CST
Apigee, a technology company that helps businesses become leaders in today's mobile world, today released the findings of its "2013 Digital Impact Survey." The survey of 1,000 smartphone-owners in the U.S. explored how apps are changing day-to-day behaviors and how consumers expect technological changes on the horizon to affect them. The survey findings indicate that mobile apps have changed and continue to change our everyday lives -- from the way that older Americans socialize to nearly every behavior of younger Americans.

Economy Strengthens Heading Into 2014 As Cloudy Policy Debate Begins to Clear Housing Continues Its Journey Toward Normal Activity
PR Newswire - Thu Dec 19, 8:00AM CST
Recent data show that the economy and housing market continue to transition to more normal levels of activity and are poised to gather further momentum heading into 2014, according to Fannie Mae's (FNMA/OTC) Economic & Strategic Research Group. In particular, as uncertainty surrounding fiscal and monetary policy wanes, consumer spending and manufacturing activity should improve and contribute to additional housing growth. Real economic growth is expected to come in at approximately 2.2 percent for all of 2013, which is roughly in line with the Group's forecast at the beginning of this year, with an increase to 2.7 percent expected next year.

SafeCode Drug Technologies to Hire Project Manager to Market FDA Approved Painless Injection Device
PR Newswire - Wed Apr 17, 7:30AM CDT
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of technologies that reduces errors and eliminates pain during the administration of prescription medications, announced today that the company intends to hire a Project Manager to oversee and implement a marketing strategy to commercialize its newly acquired painless injection device.

SafeCode Drug Technologies Initiating Activities to Commercialize its Recent Newly Acquired Technology of the Pain-Free Injection
PR Newswire - Thu Mar 21, 8:00AM CDT
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of voice activated drug safety application announced today that the company is actively initiating a business development plan to commercialize its newly acquired technology.

SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
M2 - Tue Mar 12, 9:19AM CDT
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, announced today that the company has acquired breakthrough Quickool technology enabling individuals to self-administer pain free injections.

Medisafe 1 Technologies One-Time Special Dividend Announced
PR Newswire - Thu Feb 21, 7:40AM CST
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.

Monday's Most Active MicroCaps: China Logistics Group (OTCBB: CHLO), SafeCode Drug Technologies (OTCBB: SAFC), and World Moto (OTCBB: FARE)
ACCESSWIRE-TNW - Mon Jan 07, 10:45AM CST
Dallas, TX, Jan 07, 2013 (ACCESSWIRE-TNW via COMTEX) - www.Expedated.com brings you today's most active micro-cap stocks investors are flocking to: China Logistics Group, Inc. (OTCBB: CHLO), SafeCode Drug Technologies Corp. (OTCBB: SAFC), and World Moto, Inc. (OTCBB: FARE).

Safecode Drug Technologies Receives Investment From Biomedix Ltd
M2 - Mon Jan 07, 8:35AM CST
JERUSALEM, January 7, 2013 -- Israel's publicly-traded (TASE) BioMedix Agrees to Purchase SAFC at 0.15 cents Per Share

SafeCode Drug Technologies Corporation Announce Share Buy Back Program
PR Newswire - Wed Jan 02, 7:45AM CST
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a voice recognition drug administration safety application announced today that the share Buyback Program which was authorized by the Board Of Directors will commence during the month of January 2013 and is expected to last approximately 1-3 months. The shares will be returned to the Treasury of the Company to be used for further issuances for future acquisitions of companies or technology applications in the medical industry. Funding for the acquisition of the shares will be subject to financing from third parties.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading